Skip to main content

DarioHealth Corp

For the period ended Dec 31, 2024. Filed Mar 10, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 10, 2025

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​20242023
ASSETS​​​​​​
​​​​​​​
CURRENT ASSETS: · ​ · ​
Cash and cash equivalents​$27,764​$36,797
Short-term bank deposits​​697​​-
Short-term restricted bank deposits​175​292
Trade receivables, net​4,804​3,155
Inventories​4,753​5,062
Other accounts receivable and prepaid expenses​2,336​2,024
​​​​​​​
Total current assets​40,529​47,330
​​​​​​​
NON-CURRENT ASSETS:​​​​
Deposits​​79​​6
Operating lease right of use assets​1,065​967
Long-term assets​​313​​143
Property and equipment, net​​709​​899
Intangible assets, net​​18,762​​5,404
Goodwill​​57,427​​41,640
​​​​​​​
Total non-current assets​​78,355​​49,059
​​​​​​​
Total assets​$118,884​$96,389

CONSOLIDATED BALANCE SHEETS

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · 2024 · 2023
LIABILITIES AND STOCKHOLDERS’ EQUITY · ​ · ​ · ​ · ​
​​​​​​​
CURRENT LIABILITIES: · ​ · ​
Trade payables​$3,045​$1,131
Deferred revenues​1,583​997
Operating lease liabilities​​504​​111
Other accounts payable and accrued expenses​6,052​6,300
Current maturity of long-term loan​​5,451​​3,954
​​​​​​​
Total current liabilities​16,635​12,493
​​​​​​​
NON-CURRENT LIABILITIES​​​​​​
Operating lease liabilities​765​885
Long-term loan​23,472​24,591
Warrant liability​​5,968​​240
Other long-term liabilities​25​36
​​​​​​​
Total non-current liabilities​​30,230​​25,752
​​​​​​​
STOCKHOLDERS’ EQUITY​​​​
Common stock of $0.0001 par value - authorized: 160,000,000 shares; issued and outstanding: 38,388,431 and 27,191,849 shares on December 31, 2024 and December 31, 2023, respectively​4​3
Preferred stock of $0.0001 par value - authorized: 5,000,000 shares; issued and outstanding: 49,585 and 18,959 shares on December 31, 2024 and December 31, 2023, respectively​*) -​*) -
Additional paid-in capital​462,358​407,502
Accumulated deficit​(390,343)​(349,361)
​​​​​​​
Total stockholders’ equity​72,019​58,144
​​​​​​​
Total liabilities and stockholders’ equity​$118,884​$96,389

*) Represents an amount lower than $1.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.